MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION 15 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 15 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “MDxHealth”), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May […]
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 8, 2021, 22:30 CET MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States IRVINE, CA, and HERSTAL, BELGIUM – November 8, 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announces, in accordance with Article 15 of […]
MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATION4 NOVEMBER 2021, 13:00 CET MDxHealth Announces Pricing of Initial Public Offering of ADSsin the United States IRVINE, CA, and HERSTAL, BELGIUM – November 4, 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announced the pricing of its initial […]
MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATION28 OCTOBER 2021, 07:00 CEST MDxHealth Announces Launch of Proposed Initial Public Offering of ADSsin the United States IRVINE, CA, and HERSTAL, BELGIUM – October 28, 2021 – MDxHealth SA (Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it is launching a registered […]
MDxHealth Provides Q3-2021 Business Update
NEWS RELEASE – REGULATED INFORMATION21 OCTOBER 2021, 07:00 A.M. CET MDxHealth Provides Q3-2021 Business Update IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2021 – MDxHealth SA (Euronext: MDXH.BR) (“MDxHealth” or the “Company”), a commercial-stage precision diagnostics company, today provided a business update for the third quarter ended September 30, 2021. Michael K. McGarrity, CEO […]
MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States
NEWS RELEASE – REGULATED INFORMATION13 OCTOBER 2021, 19:30 CET MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States IRVINE, CA, and HERSTAL, BELGIUM – October 13, 2021 – MDxHealth SA (Euronext: MDXH.BR) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that the Company has publicly filed a registration […]
MDxHealth Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONSeptember 1, 2021, 18:00 CEST MDxHealth Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States IRVINE, CA, and HERSTAL, BELGIUM – September 1, 2021 – MDxHealth SA (Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it has […]
MDxHealth Reports Half Year 2021 Results
NEWS RELEASE – REGULATED INFORMATION26 AUGUST 2021, 18:00 CET MDxHealth Reports Half Year 2021 Results Conference call with Q&A today at 19:00 CET / 1PM US ET, details provided below IRVINE, CA, and HERSTAL, BELGIUM – August 26, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage precision diagnostics company, today announced its financial results for […]
MDxHealth to Present First Half 2021 Financial Results and Corporate Update on August 26
Company to Host Conference Call and Live Q&A Session, August 26, 2021, at 10:00am PT/ 1:00pm ET/ 19:00 CET IRVINE, CA, and HERSTAL, BELGIUM – August 12, 2021, 1:00 AM (CET)– MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative precision diagnostics company, today announced it will release its financial results for the half year ended June 30, […]
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 27 May 2021, 23:00 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 27 May 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“) a commercial-stage innovative molecular diagnostics company, today held its annual general shareholders’ meeting (“AGM“) and an extraordinary general shareholders’ meeting (“EGM“) The items on the […]
